BRONQUIDIAZINA

This brand name is authorized in Nigeria.

Active ingredients

The drug BRONQUIDIAZINA contains a combination of these active pharmaceutical ingredients (APIs):

1	Sulfamethoxazole UNII JE42381TNV - SULFAMETHOXAZOLE
	Sulfamethoxazole competitively inhibits the utilisation of para-aminobenzoic acid in the synthesis of dihydrofolate by the bacterial cell resulting in bacteriostasis.
	Read more about Sulfamethoxazole
2	Trimethoprim UNII AN164J8Y0X - TRIMETHOPRIM
	Trimethoprim is a dihydrofolate reductase inhibitor, inhibiting the conversion of bacterial dihydrofolic acid to tetrahydrofolic acid, required for the synthesis of some amino acids. Its effects are considerably greater on the cells of micro-organisms than on the mammalian cells.
	Read more about Trimethoprim

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-2538	Suspension	BRONQUIDIAZINA C.R. SUSPENSION 150ML SUSP 400 mg; 80 mg 150ML	55 RNW-PP-344986 BRONQUIDIAZINA C.R. SUSPENSION 150ML TRIMETHOPRIM 80mg; SULPHAMETOXAZOL 4OOmg;BROMHEXINE HCL 4m ;SODIUM BENZOATE 250mg; TOLU BALSAM SYRUP 325mg Trimethoprim(80mg); Sulphametoxazol(400mg)Bromhexine(25omdium benzoate (250mg)Tolu Balsam Syrup (325mg) Excipients: Glycerol (E-422) 443.125mg;Sucrose-415mg;Methyl parahydroxybenzoate(E-218)-15mg; Propylparahydroxybenzoate (E-216)-3.75mg;Xanthan gum;sodium saccharine;polysorbate 80;dimethlpolysiloxane anti-foaming agent;Aniseed essence;water,q.s. B4-2538 Drugs Imported Products 150ML Prescription Only Medicine (POM) 10/16/2023 FAES FARMA NIGERIA LIMITED, 25D LADOKE AKINTOLA GRA, IKEJA LAGOS LAGOS FAES FARMA SPAIN, Maximo Aguirre 14 48940 Leioa (Vizcaya) Spain, Spain	27/03/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01EE01	Sulfamethoxazole and trimethoprim	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01E Sulfonamides and trimethoprim → J01EE Combinations of sulfonamides and trimethoprim, incl. derivatives
Discover more medicines within J01EE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-2538